Method, server, and computer program for classifying severe cognitive impairment patients by analyzing EEG data

    公开(公告)号:US11547346B2

    公开(公告)日:2023-01-10

    申请号:US17680235

    申请日:2022-02-24

    申请人: IMEDISYNC, INC.

    摘要: Provided is a method for classifying severe cognitive impairment patients by analyzing electroencephalogram (EEG) data. The method of classifying severe cognitive impairment patients by analyzing EEG data includes a brainwave collection step of collecting EEG data on a plurality of users, a first classification step of classifying the plurality of users into a severe cognitive impairment group or a non-severe cognitive impairment group by analyzing the collected EEG data, a second classification step of classifying users included in the non-severe cognitive impairment group into a normal group or an amnestic mild cognitive impairment (aMCI) group, and a third classification group of classifying users included in the normal group into a within normal limits (WNL) group or a preclinical Alzheimer's disease (AD) group and classifying users included in the aMCI group into a non-AD MCI group or a prodromal AD group.

    METHOD, SERVER, AND COMPUTER PROGRAM FOR CLASSIFYING SEVERE COGNITIVE IMPAIRMENT PATIENTS BY ANALYZING EEG DATA

    公开(公告)号:US20220287621A1

    公开(公告)日:2022-09-15

    申请号:US17680235

    申请日:2022-02-24

    申请人: IMEDISYNC, INC.

    摘要: Provided is a method for classifying severe cognitive impairment patients by analyzing electroencephalogram (EEG) data. The method of classifying severe cognitive impairment patients by analyzing EEG data includes a brainwave collection step of collecting EEG data on a plurality of users, a first classification step of classifying the plurality of users into a severe cognitive impairment group or a non-severe cognitive impairment group by analyzing the collected EEG data, a second classification step of classifying users included in the non-severe cognitive impairment group into a normal group or an amnestic mild cognitive impairment (aMCI) group, and a third classification group of classifying users included in the normal group into a within normal limits (WNL) group or a preclinical Alzheimer's disease (AD) group and classifying users included in the aMCI group into a non-AD MCI group or a prodromal AD group.